Showing results (551-560 of 624) with videos related to
Sort By:
Pageof 63
Plos Neglected Tropical Diseases|September 27, 2021
A dengue outbreak in a rural community in Northern Coastal Ecuador: An analysis using unmanned aerial vehicle mappingGwenyth O Lee, Luis Vasco, Sully Márquez, et al.Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysisSully Márquez, Belén Prado-Vivar, Juan José Guadalupe, et al.The New Phytologist|September 16, 2025
Physical constraints and environmental factors shape phloem anatomical traits in woody angiosperm speciesYan Wang, Johannes Liesche, Alan Crivellaro, et al.Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Integrated serosurveillance to assess disease elimination in coastal Ecuador: onchocerciasis, yaws, and trachomaLesly Simbaña Vivanco, Stuart Torres Ayala, Nikolina Walas, et al.The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.Revista Espanola De Enfermedades Digestivas|May 31, 2022
Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unitAinhoa Fernández, Clara Díez-Picazo, Carmen Iglesias Sobrino, et al.Archivos De Bronconeumologia|March 17, 2009
[Analysis of the current situation and outlook of thoracic surgery]Jordi Freixinet, Araceli Caballero-Hidalgo, Beatriz González López-Valcárcel, et al.New Microbes and New Infections|July 12, 2022
First case of within-host co-infection of different SARS-CoV-2 variants in EcuadorJ C Fernandez-Cadena, M Carvajal, E Muñoz, et al.Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.Lancet Regional Health. Americas|July 22, 2022
Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological surveyGabriel Trueba, Vishali Jeyaseelan, Lazaro Lopez, et al.Pageof 63